The Research of Constructing a Risk Assessment Model for Gastric Cancer Based on Machine Learning

NCT ID: NCT04957407

Last Updated: 2021-07-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Based on the gastric cancer database established earlier, this project explored the PG standard suitable for Chinese people, and further explored the establishment of machine learning model to stratify gastric cancer risk in the population, guide the frequency of gastroscopy screening, and extract important gastric cancer risk factors from it.Establish electronic health records of gastric organs, track the development and outcome of gastric diseases through deep learning method, in order to predict the development and outcome of gastric diseases;Then, the simulation hypothesis deductive method is used to compare the outcomes that may be caused by different lifestyles with the help of deep learning model, so as to guide patients to develop a better lifestyle and explore the establishment of health management paths for gastric cancer patients and high-risk groups in China.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Cancer Precancerous Lesion Mechine Learning

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

non-atrophic gastritis

OLGA-0 group;OLGA (Operative Link on Gastritis Assessment)

No interventions assigned to this group

mild-moderate atrophic gastritis

OLGA I-II group;OLGA (Operative Link on Gastritis Assessment)

No interventions assigned to this group

severe atrophic gastritis

OLGA III-IV group;OLGA (Operative Link on Gastritis Assessment)

pepsinogen

Intervention Type OTHER

diagnostic value of pepsinogen for severe atrophy and gastric cancer

gastric cancer

gastric cancer

pepsinogen

Intervention Type OTHER

diagnostic value of pepsinogen for severe atrophy and gastric cancer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pepsinogen

diagnostic value of pepsinogen for severe atrophy and gastric cancer

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1) intention to undergo gastroscopy during health checkup examination; and 2) 25-75 years of age

Exclusion Criteria

* 1\) a history of gastric ulcer, gastric polyp, or GC; 2) a history of gastrectomy; 3) treatment with a proton pump inhibitor in the last month; 4) contraindications to gastroscopy; 5) a history of Hp eradication; 6) a history of abdominal pain, abdominal distention, belching, acid reflux, nausea and other digestive tract symptoms within 1 month or 67) incomplete data.
Minimum Eligible Age

25 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yuling Tong, Dr.

Role: PRINCIPAL_INVESTIGATOR

2nd affiliated hospital of Zhejiang University, school of medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhejiang Provincial Hospital of Traditional Chinese Medicine

Hangzhou, , China

Site Status RECRUITING

Ningbo cadres health center

Ningbo, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yuling Tong, Dr.

Role: CONTACT

1375821220

Yi Zhao, Master

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xuan Huang

Role: primary

Tong Huang

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

71804161

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.